04:46 PM EDT, 04/22/2024 (MT Newswires) -- Andrew Guggenhime, President and CFO, on April 18, 2024, sold 8,000 shares in Vaxcyte ( PCVX ) for $490,199. Following the Form 4 filing with the SEC, Guggenhime has control over a total of 95,679 shares of the company, with 95,679 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1649094/000141588924011322/xslF345X03/form4-04222024_080406.xml